DANIEL DIETRICK was named chief value officer at Chesapeake Urology. His primary function is to oversee patient safety and healthcare quality. He will execute on the overall clinical vision and strategy of the organization, maintaining professional and quality control standards, and creating and overseeing processes to improve quality, efficiency, and cost effectiveness in Chesapeake Urology’s...
The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.
